研究员,生物发现/Research Investigator, Discovery Biology (博士)当面告知
百濟神州有限公司
2026-12-15 15:28:34
校招博士27届
岗位详情
地区:
北京
·
上海
专业要求:
专业不限
岗位职责:
General Description:
We are seeking a talented Research Investigator to join our Discovery Biology team. In this role, you will be embedded within cross‑functional project teams and contribute across the full discovery continuum—from new target proposal and target evaluation/validation, through hit/lead discovery and lead optimization, to candidate selection and IND‑enabling readiness. You will collaborate closely with partners across discovery functions (e.g., chemistry, molecular sciences, in vivo pharmacology, DMPK and safety) to translate complex disease/target biology questions into actionable experimental plans, enabling a strong and diversified preclinical pipeline across both traditional and emerging modalities.
Responsibilities:
Develop and optimize cell line- or primary cell-based assays under the supervision of a group leader, using colorimetric, fluorogenic or imaging readouts in a low, medium, or high throughput format to meet project requirements
Develop and execute target validation plan for new research proposals via independently reviewing and summarizing literature data under the guidance of a senior leader.
Close work with cross-functional team and engage in cross-disciplinary scientific discussion, and act as functional representative to provide expertise for in vitro cellular based experiments.
Troubleshoot and resolve complex problems in cellular assay development by undertaking innovative approaches under the guidance of a senior leader
Generate, analyze, and interpret data in appropriate scientific context, and present data in both written and verbal formats to internal and external stakeholders
Qualifications:
PhD in the disciplines of medical and life sciences; specialty in cell biology, molecular biology, genetics, epigenetics, cancer biology or immunology;
Strong cancer biology or immunology knowhow and track record of scientific accomplishment at high standards;
Extensive expertise in cloning, mammalian cell culture, transfection/transduction, siRNA KD, CRISPR KO,
and immunocytochemistry/immunofluorescence is required;
Highly self-motivated and capable of handling and prioritizing tasks from multiple parallel projects;
Good communication and presentation skills in both Chinese and English.
招聘要求:
General Description:
We are seeking a talented Research Investigator to join our Discovery Biology team. In this role, you will be embedded within cross‑functional project teams and contribute across the full discovery continuum—from new target proposal and target evaluation/validation, through hit/lead discovery and lead optimization, to candidate selection and IND‑enabling readiness. You will collaborate closely with partners across discovery functions (e.g., chemistry, molecular sciences, in vivo pharmacology, DMPK and safety) to translate complex disease/target biology questions into actionable experimental plans, enabling a strong and diversified preclinical pipeline across both traditional and emerging modalities.
Responsibilities:
Develop and optimize cell line- or primary cell-based assays under the supervision of a group leader, using colorimetric, fluorogenic or imaging readouts in a low, medium, or high throughput format to meet project requirements
Develop and execute target validation plan for new research proposals via independently reviewing and summarizing literature data under the guidance of a senior leader.
Close work with cross-functional team and engage in cross-disciplinary scientific discussion, and act as functional representative to provide expertise for in vitro cellular based experiments.
Troubleshoot and resolve complex problems in cellular assay development by undertaking innovative approaches under the guidance of a senior leader
Generate, analyze, and interpret data in appropriate scientific context, and present data in both written and verbal formats to internal and external stakeholders
Qualifications:
PhD in the disciplines of medical and life sciences; specialty in cell biology, molecular biology, genetics, epigenetics, cancer biology or immunology;
Strong cancer biology or immunology knowhow and track record of scientific accomplishment at high standards;
Extensive expertise in cloning, mammalian cell culture, transfection/transduction, siRNA KD, CRISPR KO,
and immunocytochemistry/immunofluorescence is required;
Highly self-motivated and capable of handling and prioritizing tasks from multiple parallel projects;
Good communication and presentation skills in both Chinese and English.
公司介绍

百濟神州有限公司
百濟神州有限公司,成立于2018-06-28,位于香港,登记状态:仍注册,注册资本15.4142万美元,公司类型:中外合资
百济神州有限公司是一家商业化阶段的生物技术公司,专注于开发及商业化用于治疗癌症的创新型分子靶向及肿瘤免疫治疗药物。百济神州拥有广泛全面的产品组合。其产品包括六种内部开发、临床阶段的候选药物,其中包括三种后期临床候选药物,zanubrutinib(BTK抑制剂),tislelizumab(PD-1抗体)与pamiparib(PARP抑制剂)。百济神州亦获得五种药物及在研药物的授权许可,包括三种已于中国销售的由新基独家授权的药物ABRAXANE、REVLIMID 及VIDAZA,及两种临床阶段的在研药物,该种药物已获得于中国及亚太地区的其他指定国家开发及商业化的权利。百济神州于2010年于北京成立并在2016年2月在美国纳斯达克全球精选市场上市。截至2018年7月,公司拥有一支超过1300名员工的全球团队,成为一家拥有涵盖研究、临床开发、生产及商业化的全面实力的全球生物技术公司。